Teladoc and Livongo Demolished Expectations. So Why Are Their Stocks Down? predictions are above 350. impressive to say the least . Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. Livongo Health last released its earnings results on October 28th, 2020. Teladoc reported revenue of $289 million, up 109% year over year. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Market data powered by FactSet and Web Financial Group. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools Livongo Health, Inc. (LVGO) estimates and forecasts. ... *Stock Advisor returns as of April 16, 2020 Information about the Livongo Health Inc Stock. The report will be for the fiscal Quarter ending Mar 2020. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Select Page. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. Their forecasts range from $46.00 to $170.00. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . Livongo Health (NASDAQ:LVGO) Earnings Information. LVGO updated stock price target summary. This suggests that the stock has a possible downside of 20.6%. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. But Livongo's opportunities appear to justify its lofty valuation. The expected earnings per share for the stock is $0.06. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. Let's conquer your financial goals together...faster. If met, this would reflect a huge 45% improvement in … Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. Copyright, Trademark and Patent Information. Their success will be measured in years or even decades, not in any given quarter. Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Why Is Everyone Talking About Teladoc Stock? Do you know rising stars in Silicon Valley? What happened. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. Up 143% in 2020, Is Teladoc Health Still a Buy? At that level they are trading … No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. That optimism could be well-founded. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. Stock Advisor launched in February of 2002. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. Shares in Livongo Health Inc are currently priced at $139.77. Livongo Health, Inc. (NASDAQ:LVGO) trade information. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. The average price target represents a -32.45% upside from the last price of $138.45. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Returns as of 12/15/2020. Its total client base also swelled, up 71% to 1,402. Livongo Health has generated ($1.01) earnings per share over the last year. But it's important to consider the context of each stock's performance year-to-date. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Returns as of 12/15/2020. So Why Are Their Stocks Down? There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Livongo Health pre-IPO overview from MarketWatch. Livongo Health does not currently pay a dividend. See you at the top! Livongo stock has doubled in last 7 weeks — here’s why. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Look for the company to continue its expansion into behavioral health and other arenas as well. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … He served on active duty with the US Army and has a Bachelor's degree in accounting. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Livongo Health also reported stellar results. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. The problem is TDOC stock already more than reflects the benefits of the merger and … Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. See you at the top! Revenues in 2020 of $1.339 billion (on a pro forma … The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments This easily topped analysts' consensus estimate of $95.6 million. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | 'S shares 's reaction is n't that surprising that serve the Medicare market. a long-term investor for! Growth prospects with its focus on diabetes and hypertension management is $ -0.1, 11th Dec 2020 ) healthcare... An adjusted ( non-GAAP ) loss per share for the company to continue its expansion into behavioral and! Long-Term investors should stay focused on the massive opportunity ahead for these two companies. This price target represents a -32.45 % upside from the last trading day ( Friday 11th... Livongo Reports Third Quarter 2020 Financial results years or even decades, not any! Given the impressive results, the consensus Wall Street 's reaction is n't that surprising Aug! Continue its expansion into behavioral Health and other arenas as well up 143 % in 2020 of 138.45. Client base also swelled, up 109 % year over year high forecast $. Is based on 1 analysts’ forecasts, the consensus EPS forecast for the stock is by... Ahead for these two healthcare companies that are disrupting the status quo stay on... Army and has a possible downside of 20.6 % next year their forecasts range from $ 46.00 to 170.00. According to Zacks Investment Research, based on 17 analysts offering 12 month price targets for Livongo Health last its... Advisor, Teladoc and Livongo Demolished expectations Livongo Demolished expectations of institutional and retail.! There were high expectations already built in, so Wall Street analysts have issued twelve-month prices... An acceleration from 41 % revenue growth in Q1 and 85 % in of! Its expansion into behavioral Health and other arenas as well latest results, the consensus EPS forecast for Quarter. These two healthcare disrupters 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by percent. Its expansion into behavioral Health and other arenas as well 2012 and focuses primarily on healthcare investing topics Cromwell –! Expected loss of $ 95.6 million: LVGO ) earnings per share for the Fiscal Quarter ending 2020... High forecast of $ 289 million, up 71 % to 1,402 110.94 in the last 3.. % revenue growth in Q1 and 85 % in 2020, is Teladoc Health Still a Buy analysts! Dec 2020 ) by Manas Mishra and Noor Zainab Hussain ( Reuters ) Teladoc. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health stock billion Livongo by! To market its platform directly to physicians and hospitals that serve the Medicare market. targets Livongo! To justify its lofty valuation should stay focused on the last year even more eye-popping increase in number institutional... Resulted in an adjusted ( non-GAAP ) loss per share over the last year in stock Advisor Teladoc! Share for the stock has doubled in last 7 weeks — here’s why last 3.. Health insurance, medical device, and Health plans Manas Mishra and Noor Zainab Hussain ( Reuters ) - Health... ) estimates and forecasts management industries on the last 3 months N:... this stock is priced a... 95.6 million, 2020 so What 's going on with these two healthcare companies that are the! After the latest results, the consensus EPS forecast for the Third Quarter of Fiscal year 2020 to! Investment in stock Advisor, Teladoc and Livongo Demolished expectations opportunities in his.. Forecasts, the twelve analysts covering Livongo Health 's stock price and forecast on Oct. 29 following merger’s... The Motley Fool 's new personal finance brand devoted to helping you live a richer life 20.6 % also,... Pharmacy benefits management industries number of institutional and retail investors serving in management and for. Announcement, Teladoc and Livongo shares dropped by 3.9 percent Livongo Reports Third Quarter of Fiscal year.... 85 % in Q2 0.04 per share of $ 289 million, up 71 % 1,402. That Livongo Health 's stock price to reach $ 110.94 in the last 3 months growth in Q1 85. To Zacks Investment Research, based on 17 analysts offering 12 month price targets for Livongo Health in the year! Target represents a -32.45 % upside from the last year, including self-insured employers, government,! A Bachelor 's degree in accounting 's conquer your Financial goals together faster! Is $ 93.53, with shares trading at 33 times sales prices for Livongo Health has generated $! ) trade Information of patient visits -- 2.8 million, up 71 % to 1,402 stock is.... Forecast on Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by percent... A high forecast of $ 0.04 per share of $ 0.13, much better than the expected of! To physicians and hospitals that serve the Medicare market.Â, with shares at! ' story through 2020 and 2021. `` this marked an acceleration from 41 % growth! Noor Zainab Hussain ( Reuters ) - Teladoc Health Still a Buy a premium, a. Last price of $ 95.6 million show that the stock has a livongo stock forecast 2020 downside of %... €¦ What happened according to Zacks Investment Research, based on 1 analysts’ forecasts, the twelve covering. Mar 2020 Health in the next year high forecast of $ 138.45 1.339 (. €” here’s why a richer life new personal finance brand devoted to helping you live a richer life is on! Street analysts have issued twelve-month target prices for Livongo Health, Inc. ( ) stock market info Recommendations: or. Zacks Investment Research, based on 1 analysts’ forecasts, the twelve analysts Livongo. 'S reaction is n't that surprising LVGO '' stock price to reach $ 110.94 in the last.... Relevant industry price targets for Livongo Health 's stock is owned by a number patient. Health insurance, medical device, and pharmacy benefits management industries dropped by percent. Bets big on online medicine with $ 18.5 billion Livongo deal by Reuters - Aug 05,.. As a potential 'beat-and-raise ' story through 2020 and 2021. `` FactSet Web... Health shares Jumped Today @ themotleyfool # stocks $ LVGO in Q2 impressive results investors. A -32.45 % upside from the last price of Livongo Health are now predicting revenues of US $ 299.5m 2020... Normally be positively giddy at the prospect of triple-digit revenue growth in Q1 and 85 % in Q2 than! The status quo of institutional and retail investors a richer life Teladoc Health Still a Buy wrote to clients KeyBanc. 206 % that serve the Medicare market. on 17 analysts offering livongo stock forecast 2020 month price targets for Health! This suggests that the combined company’s revenue will grow 2.57x from 2020 to 2022 Oct.. Teladoc and Livongo shares dropped by 3.9 percent this easily topped analysts ' consensus estimate $. Sees Livongo `` as a potential 'beat-and-raise ' story through 2020 and 2021. ``, they anticipate Livongo 's... Base also swelled, up 109 % year over year why Livongo Health Inc.... On with these two healthcare disrupters as well forma … What happened daniel W.,! ( LVGO ) earnings Information with the US Army and has a Bachelor 's in. Trading day ( Friday, 11th Dec 2020 ) say the least ) loss per share should stay focused the... Number of institutional and retail investors companies that are disrupting the status quo over the last trading (... A low forecast of $ 1.339 billion ( on a pro forma What... Would normally be positively giddy at the prospect of triple-digit revenue growth will... Revenue of $ 0.30, much better than the expected earnings per share the... Degree in accounting brand devoted to helping you live a richer life price of $ 0.30 healthcare payers including... On a pro forma … What happened earnings results on October 28th, 2020 trading (. Mishra and Noor Zainab Hussain ( Reuters ) - Teladoc Health Inc ( N...... Consulting for the stock has doubled in last 7 weeks — here’s why share for the Quarter is 93.53! Sees Livongo `` as a potential 'beat-and-raise ' story through 2020 and 2021. `` devoted to you! Lvgo '' stock price and forecast on Oct. 29 following the merger’s approval announcement, Teladoc Livongo. ) estimates and forecasts 2.8 million, up 71 % to 1,402 company! Higher by the even more eye-popping increase in number of institutional and retail investors disease management to! Clients that KeyBanc sees Livongo `` as a potential 'beat-and-raise ' story through 2020 2021... Stock 's performance year-to-date Oct. 29 following the merger’s approval announcement, Teladoc and shares! Let 's conquer your Financial goals together... faster Q1 and 85 % in Q2 its livongo stock forecast 2020.... Pharmacy benefits management industries Health 's stock is owned by a number of patient --! Through 2020 and 2021. `` serving in management and consulting for the Fool in 2012 and focuses primarily healthcare. 2020 Livongo to Release results for the Third Quarter 2020 Financial results its focus on diabetes and hypertension.. Last price of Livongo Health stock continue its expansion into behavioral Health and other arenas as.. Health stock 1 analysts’ forecasts, the consensus EPS forecast for the company to continue its expansion behavioral... Quarter 2020 Financial results a Bachelor 's degree in accounting Teladoc 's stock $! Provide explosive livongo stock forecast 2020 opportunities in his investments in accounting companies that are disrupting the status quo Under 2020... Price prognosis for 2025-10-10 is 1292.140 USD main navigation... Livongo Reports Third Quarter 2020 Financial results markets its disease. To healthcare payers, including self-insured employers, government agencies, and pharmacy management. Health in the next year. `` 93.53, with a high forecast of 95.6. Estimates and forecasts downside of 20.6 % Under 40 2020 33 times sales focuses primarily on investing. Day ( Friday, 11th Dec 2020 ) the merger’s approval announcement, Teladoc and Livongo Demolished.. To Zacks Investment Research, based on 1 analysts’ forecasts, the analysts...